Protein Found in Insulin-secreting Cells Linked to Obesity and Metabolic Dysfunction without Consuming Excess Calories
American Physiological Society (APS)
In a pioneering breakthrough within the realm of literature, scientists have harnessed the power of purified beta-glucanase to transform broiler wheat diets.
The world’s total population is expected to reach 9.9 billion by 2050. This rapid increase in population is boosting the demand for agriculture to cater for the increased demand. Below are some of the latest research and features on agriculture and farming in the Agriculture channel on Newswise.
By: Bill Wellock | Published: November 14, 2023 | 2:43 pm | SHARE: The U.S. Food and Drug Administration recently approved the medication Zepbound for weight management treatment.Tirzepatide, the active ingredient in the Eli Lilly and Company’s trademarked Zepbound, was already approved to help improve blood sugar (glucose) in adults with type 2 diabetes mellitus.
In what is believed to be the largest study of the association between BMI and postoperative complications following chest masculinization surgery, researchers at the Johns Hopkins Center for Transgender and Gender Expansive Health provide evidence that BMI is a poor metric for determining who should be approved for the gender transitioning procedure.
New study shows that most people taking semaglutide do not develop diabetic retinopathy or experience a worsening of existing diabetic retinopathy.
A new large-scale study led by researchers at the University of Cincinnati and Northwell Health, New York's largest health care provider, found the drug metformin can help prevent or reduce weight gain in youth taking medication to treat bipolar disorder.
More weight lost among people who fasted, compared to calorie restriction
Patients with previous bariatric surgery who undergo body contouring (BC) regain more weight at long-term follow-up, compared to BC patients who did not have bariatric surgery, reports a study in the November issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
In a first-of-its-kind study, researchers from the University of California, Irvine have discovered an extraordinary surge in the utilization of weight loss-associated GLP-1 receptor agonists, a class of medications commonly used in the treatment of Type 2 diabetes and obesity, that is poised to accelerate, based on emerging clinical evidence.
Scientists from Immanuel Kant Baltic Federal University on the base of literary sources have described in detail the connection between intracellular processes in mitochondria and metabolic disorders in human’s organism that lead to obesity and cardiovascular diseases.
The Integrated Program is dedicated to helping people lose weight and keep it off in the most healthy and appropriate way.
Improving insulin resistance with metformin, a medication used to treat Type 2 diabetes, reduced the chances of developing kidney disease in a prepubescent obese rat model, according to a new study from the University of Mississippi Medical Center.
Scientists have uncovered why night shift work is associated with changes in appetite in a new University of Bristol-led study. The findings, published in Communications Biology, could help the millions of people that work through the night and struggle with weight gain.
Health experts are redefining cardiovascular disease (CVD) risk, prevention and management, according to a new American Heart Association presidential advisory published today in the Association’s flagship journal Circulation.
These drugs are not the be-all and end-all to weight-loss therapy, wrote Dr. Michael Schwartz in a commentary published Oct. 2 in The Journal of Clinical Investigation. His co-author was Sophie Yang Gou, a postdoctoral fellow in Schwartz’s lab at the University of Washington School of Medicine. Many experts seem to be saying “OK, we’ve fixed this problem. We’re done,” noted Schwartz, who co-directs the UW Medicine Diabetes Institute. That is simply not the case, he said.
Researchers at University of Galway have taken a significant step forward in the management of gestational diabetes mellitus after a clinical trial involving pregnant women provided new hope for expectant mothers suffering the condition.
A UCLA-led team of researchers has found nerve pathways that supply brown adipose tissue (BAT), a type of tissue that releases chemical energy from fat metabolism as heat – a finding that could pave the way toward using it to treat obesity and related metabolic conditions.
A researcher at The University of Alabama in Huntsville (UAH) has been awarded a $179,000 subcontract to explore community-based strategies for reducing high-burden chronic disease like obesity, diabetes, heart disease and cancer as part of an overall award totaling $4.2 million.
Below are some of the latest headlines in the Women's Health channel on Newswise.
The complex relationship between physical activity and energy balance – food intake versus energy expenditure – is still a challenge for science, especially in light of the rising worldwide prevalence of overweight and obesity.
As gluten-free food options increase, it can be difficult to decide whether to include gluten in your diet or not. For most people, there is no need to completely eliminate foods containing gluten and no proven benefit from doing so, says Sarmed Sami, MBChB, a gastroenterologist at Mayo Clinic Healthcare in London.
A new drug encourages weight loss and increases endurance by making the body act like it is exercising.
The early treatment of obesity in children is effective in both the short and long term, researchers from Karolinska Institutet report in a study published in The International Journal of Obesity.
When it comes to weight loss, nuts can get a bad rap – while they’re high in protein, they’re also high in fats, and this often deters those looking to shed a few kilos. But new research from the University of South Australia shows that you can eat almonds and lose weight too.
Certain genetic influences contribute to disordered eating and problematic alcohol use, leaving some people vulnerable to both conditions, according to a large study of late adolescent twins. Previous research has found concurrent eating disorders and risky drinking in younger teens amplify the chance of worse outcomes, including death.
Views around obesity are closely tied up with political values and wider social attitudes, suggesting that tackling weight stigma may require tackling other forms of stigma, new research led by the University of Bristol, UK, has found.
“The number of people with obesity is rising in every country across the world. Our study is the first to demonstrate that this increasing burden of obesity is translating into rising heart disease deaths,” said lead study author and cardiologist Zahra Raisi-Estabragh, M.D., a clinical lecturer at the William Harvey Research Institute in London.
A new opinion piece published in Health Affairs Forefront raises questions around current approaches to assess drug safety and effectiveness in people with obesity.
Researchers from Oregon Health & Science University identified a potential mechanism behind eating a high-fat diet during pregnancy and asthma in offspring. The study is published in the American Journal of Physiology-Lung Cellular and Molecular Physiology and was chosen as an APSselect article.
Semaglutide improves heart failure-related symptoms and physical function and results in greater weight loss compared with placebo in patients with heart failure with preserved ejection fraction (HFpEF) and obesity, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.
The science is unclear on exactly why an increasingly popular new class of federally approved diabetes and obesity medications work, but they do know that they are effective at helping people lose weight.
Researchers from the University of California, Irvine have just published a study that projects 93 million U.S. adults that are overweight and obese may be suitable for the 2.4 mg dosage of semaglutide, a weight loss medication known under the brand name Wegovy.
A new study by Texas A&M AgriLife revealed a range of health and dietary benefits of consuming cardamom, including increased appetite, fat loss and inflammation reduction, making the spice a “superfood.”
It's that time of year again. For media working on stories about the seasonal return to school, here are the latest features and experts in the Back-To-School channel on Newswise.
A researcher from the University of Warwick says that to promote better health within Western societies, it's essential to reshape our food culture. This means moving away from unhealthy, ultra-processed, sugar-laden, and fibre-depleted foods and gravitating towards wholesome, fibre-rich, plant-based foods reminiscent of the Mediterranean diet.
There’s no doubt that Aussies love a good celebration. We’re all in when it comes to the weekend, and most of us can’t go past a Christmas celebration without a little bit of overindulging. But all this comes at a cost, and it’s taking a massive toll on our waistline.
A new randomized controlled study of people with type 2 diabetes showed that study participants who restricted eating to between noon and 8 p.m. daily lost more weight than those who reduced their overall calorie intake by counting calories.
En un estudio piloto de 165 personas, los investigadores de Mayo Clinic analizaron la eficacia de dos enfoques distintos para la pérdida de peso: una intervención estándar en el estilo de vida y tratamiento individualizado. La intervención estándar en el estilo de vida comprendía una dieta reducida, ejercicio y terapia conductual.
فيدراسة تجريبية شملت 165 شخصًا، درس باحثو مايو كلينك فعّالية طريقتين مختلفتين لفقدان الوزن: تدخُّل قياسي في نمط الحياة وعلاج فردي.
Em um estudo piloto com 165 pessoas, pesquisadores da Mayo Clinic observaram a efetividade em duas abordagens de perda de peso: a intervenção no estilo de vida padrão e a terapia individualizada.
With $7 million in funding from the National Institutes of Health, researchers from Wake Forest University School of Medicine and Wake Forest University will study whether a combination of resistance training plus bone-strengthening exercises and/or osteoporosis medication use can help older adults safely lose weight without sacrificing bone mass.
A study involving more than 745,000 adolescents from 41 countries across Europe and North America identified an increase in the amount of teenagers who underestimate their body weight.
Water fasts, where people consume nothing but water, may not be a long-term weight loss strategy